Mid-Year Report

DR ACCESS PRODUCTS ABOUT CITI DEPOSITARY RECEIPT SERVICES INTERNATIONAL INVESTING TRENDS GLOBAL DR TRENDS *Signifies Citi DR program capital raising. Deals in bold italics signify a JOBS Act Deal. 1 Defined as capital raising at the time of listing of additional DR securities including rights offerings, and private placements. Data as of June 30, 2019. 2 Industry as defined by Bloomberg. Issuer Country Industry 2 USD Value (in Millions) Pinduoduo Inc. China Consumer Discretionary $1,581 Sea Limited Singapore Software & Services $1,553 Ascendis Pharma A/S Denmark Pharmaceuticals, Biotechnology $575 GDS Holdings Ltd. China Information Technology $460 HUYA Inc. China Media $442 Bilibili Inc. China Software & Services $324 Zai Lab Limited* China Pharmaceuticals, Biotechnology $230 Veon Netherlands Telecommunication Services $216 Endava plc* UK Software & Services $157 Orchard Therapeutics plc* UK Pharmaceutical $139 Autolus Therapeutics plc* UK Pharmaceuticals, Biotechnology $116 Qutoutiao Inc China Media $100 Huami Corporation China Consumer Discretionary $77 JinkoSolar Holding China Energy $75 DBV Technologies S.A.* France Pharmaceuticals, Biotechnology $33 BioLineRX Israel Pharmaceuticals, Biotechnology $15 Cellect Biotechnology Ltd. Israel Pharmaceuticals, Biotechnology $7 Foresight Autonomous Holdings Ltd Israel Technology Hardware & Equipment $6 Immuron Limited Australia Pharmaceuticals, Biotechnology $2 Grand Total $6,107 DR Follow-On Offerings 1 Source: Bloomberg and Depositary Data Interchange. 15 Citi Depositary Receipt Services Mid-Year 2019 Report